Monthly Archives: March 2013

The Government of Canada reported last week that they are working with pharmaceutical manufacturer Roche to release the neuraminidase inhibitor Tamiflu (oseltamivir) from Canadian stockpiles to ensure availability of the drug for a particularly severe flu season in Canada this year. This … Continue reading →

Since its development, mammography has been considered one of the most impressive advances in cancer screening. It is thought of as an essential tool in reducing morbidity and mortality from this highly prevalent disease. Every woman who has undergone mammography … Continue reading →

Most readers will be all too familiar with Dr Andrew Wakefield’s absurd, now fully retracted and discredited (the same goes for his medical license, thankfully) 1998 study suggesting a link between autism and vaccination. Dr Wakefield’s science was shoddy, and his … Continue reading →

Hidden data, missing data, withholding data- whatever you call it, not all clinical trial data is publicly available, and we think that’s an issue. Regardless of the description, incomplete data is an impediment to ensuring that patients get the best … Continue reading →

“But, by the words we speak and the faces we show the world, we force the spring.” The beginning of Bill Clinton’s first inaugural address seems an odd place to start a discussion about epidemiology, I admit. For us, though, it reflects … Continue reading →